Reach the investors backing rounds like this
Backed by Norrsken Launcher, Karolinska Institutet Innovation · verified emails and LinkedIn on Datapile

Eyedentity Secures €1.3 Million for AI Eye Cancer Detection - N24 Haber
Eyedentity is a MedTech startup developing AI technology to detect serious eye diseases from fundus images captured during routine eye examinations. The company aims to improve early detection of uveal melanoma, a rare but potentially deadly form of eye cancer, by integrating its AI-powered diagnostics platform into opticians, eye clinics, and hospitals.
Eyedentity Secures €1.3 Million for AI Eye Cancer Detection N24 Haber
| Sep 15, 2026 | Rebaba | $4.6M | Seed | Sweden |
| Sep 15, 2026 | Cubase Bio | $4.6M | Seed | Sweden |
| Sep 14, 2026 | Freya Industries | $564K | — | Sweden |
| Sep 07, 2026 | Fluencify | $4.0M | — | Sweden |
You just read who funded Eyedentity. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.